| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
324 |
289 |
$516K |
| 99214 |
|
4,381 |
4,261 |
$7K |
| 96401 |
|
517 |
355 |
$2K |
| 99204 |
|
515 |
515 |
$1K |
| 99213 |
|
844 |
804 |
$639.67 |
| 96413 |
|
102 |
96 |
$441.50 |
| 96372 |
|
220 |
202 |
$355.56 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
127 |
121 |
$264.25 |
| 20611 |
|
48 |
41 |
$117.35 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
62 |
58 |
$27.40 |